VasGene Therapeutics Inc.
http://www.vasgene.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From VasGene Therapeutics Inc.
AZ-Pfizer relief: 'at risk' partnerships in the clear as takeover plans fold
As the news breaks that UK big pharma AstraZeneca has rejected a final takeover bid from US giant Pfizer, several of both the firms' smaller pharma and biotech partners will be breathing a sigh of relief.
AZ-Pfizer side effects: Partnership crossover casualties coming soon?
As the Pfizer, AstraZeneca megamerger circus continues following meetings between UK government committees and both companies' chiefs executives (scripintelligence.com, 15 May 2014), Scrip has been investigating possible repercussions a takeover could have on the giant drug makers' smaller pharma and biotech partners.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice